Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Adams S, Baum RP, Stuckensen T, Bitter K, Hör G (1998) Prospective comparison of FDG PET with conventional imaging modalities CT, MRI, US in lymph node staging of head and neck cancer. Eur J Nucl Med 25:1255–1260
Assar OS, Fischbein NJ, Caputo GR et al. (1999) Metastatic head and neck cancer: Role and usefulness of FDG PET in locating occult primary tumors. Radiology 210:177–181
Bristow RE, del Carmen MG, Pannu HK et al. (2003) Clinically occult recurrent ovarian cancer: patient selection for secondary cytoreductive surgery using combined PET/CT. Gynecol Oncol 90:519–28
Burell StC, Van den Abbeele AD (2005) 2-deoxy-2-(F-18)fluoro-D-glucose-Positron emission tomography of the head and neck: An Atlas of the normal uptake and variants. Mol Imaging Biol 7:244–256
Czernin J, Auerbach (2005) Clinical PET/CT imaging: Promises and misconceptions. Nuklearmedizin Suppl 1 44: S18–23
Delgado-Bolton RC, Fernando-Perez C, Gonzalez-Meta A, Carreras JL (2003) Metaanalysis of the performance of 18FFDG PET in primary tumor detection in unknown primary tumors. J Nucl Med 44:1301–1314
Gambhir SS, Czernin J, Schwimmer J et al. (2001) A Tabulated Summary of the FDG PET Literature. J Nucl Med (Suppl) 42:1–93
Greco FA, Hainsworth JD (1993) Cancer of unknown primary site. In: Devita VT Jr, Hellma NS, Rosenberg SA (Hrsg) Cancer: principles and practice of oncology. Lippincott-Raven, Philadelphia, pp 2072–2092
Gutzeit A, Antoch G, Kühl H et al. (2005) Unknown primary tumors: Detection with dual modality PET/CT-Initial experience. Radiology 234:227–234
Haskell CM (2001) Cancer treatment. WB Saunders, Philadelphia
Hör G (2001) Impact of Clinical (Satellite-) PET in Oncolog. Siemens, Erlangen A91100-M2300-A269-1-7600:2–16
Hör G, Mantaka P (1998) Application of PET in clinical oncology. In: Limouris GS, Shukla SK, Bender HF, Biersack HJ (Hrsg) Radionuclides for oncology — current status and future aspects. Mediterra, Athens, pp 107–111
Israel O, Mor M, Guralnik L et al. (2004) Is 18 F-FDG PET/ CT useful for imaging and management of patients with suspected and occult recurrence of cancer? J Nucl Med 45:2045–2051
Johansen E, Eiftved A, Buchwald C et al. (2002) Implication of 18F-fluordeoxy-D-2 glucose positron emission tomography on management of carcionoma of unknown primary in the head and neck: A Danish cohort study. Laryngoscope 112:2009–14
Makaiova I, Vesely J, Kovacova S et al. (2002) False positive uptake of 18 FDG-fluorodeoxyglucose in the axillary brown fat lipoma (hibernoma)-case report. EANM, Abstr.
Manolidis S, Donald PJ, Volk P, Pounds TR (1998) The use of positron emission tomography scanning in occult and recurrent head and neck cancer. Acta Otolaryngol (Suppl) 534:1–11
Mantaka P, Hertel A, Adams S et al. (1998) Contribution of PET-FDG in the diagnosis of cancer of unknown primary. In: Limouris GS, Shukla SK, Bender HF, Biersack HJ (Hrsg) Radionuclides for oncology — current status and future aspects. Mediterra, Athens, pp 121–131
Regelink G, Brouwer J, de Bree R et al. (2002) Detection of unknown primary tumours and distant metastases in patients with cervical metastases:value of FDG-PET versus conventional modalities. Eur J Nucl Med 29:1024–1030
Scott CL, Cudaba I, Stewart JM et al. (2005) The utility of 2-deoxy-2-(F-18) fluoro-D-glucose positron emission tomography in the investigation of patients with disseminated carcinoma of unknown primary origin. Mol Imaging Biol 7:236–243
Sengupta MS, Lee SJ, Hoh CK et al. (1995) Utility and cost effectiveness of FDG whole body PET in patients with unknown primary malignancies (Abstr. 226). J Nucl Med 36:56
Wahl RL (2004) Why nearly all PET of abdominal and pelvic cancers will be performed as PET/CT. J Nucl Med Suppl 1 45:S81–95
von Schulthess GK (2003) Clinical Molecular Anatomic Imaging PET, PET/CT and SPECT/CT. Lippincott, London
Rights and permissions
Copyright information
© 2006 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
(2006). Cup-Tumore (Cancer of unknown primary). In: PET/CT-Atlas. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-31215-3_12
Download citation
DOI: https://doi.org/10.1007/3-540-31215-3_12
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-31214-7
Online ISBN: 978-3-540-31215-4
eBook Packages: Medicine (German Language)